These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 32352753)

  • 21. A review on coumarins as acetylcholinesterase inhibitors for Alzheimer's disease.
    Anand P; Singh B; Singh N
    Bioorg Med Chem; 2012 Feb; 20(3):1175-80. PubMed ID: 22257528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-Based Multitarget Approach for Alzheimer's Disease: Discovery of the First-In-Class Dual Inhibitor of Acetylcholinesterase and MicroRNA-15b Biogenesis.
    Gabr MT; Brogi S
    J Med Chem; 2020 Sep; 63(17):9695-9704. PubMed ID: 32787143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of acetylcholinesterase in the pathogenesis of Alzheimer's disease.
    Rees TM; Brimijoin S
    Drugs Today (Barc); 2003 Jan; 39(1):75-83. PubMed ID: 12669110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Arisugacins, selective acetylcholinesterase inhibitors of microbial origin.
    Otoguro K; Kuno F; Omura S
    Pharmacol Ther; 1997; 76(1-3):45-54. PubMed ID: 9535168
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potent Acetylcholinesterase Inhibitors: Potential Drugs for Alzheimer's Disease.
    Akıncıoğlu H; Gülçin İ
    Mini Rev Med Chem; 2020; 20(8):703-715. PubMed ID: 31902355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of new acetylcholinesterase inhibitors for Alzheimer's disease: virtual screening and
    David B; Schneider P; Schäfer P; Pietruszka J; Gohlke H
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):491-496. PubMed ID: 33478277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Design of acetylcholinesterase inhibitor for Alzheimer's disease therapy: from multi-binding site inhibitors to multi-target directed ligands].
    Yang WC; Sun Q; Yu NX; Zhu XL; Yang GF
    Yao Xue Xue Bao; 2012 Mar; 47(3):313-21. PubMed ID: 22645754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flavonoids as acetylcholinesterase inhibitors.
    Uriarte-Pueyo I; Calvo MI
    Curr Med Chem; 2011; 18(34):5289-302. PubMed ID: 22087826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis, and evaluation of 7H-thiazolo-[3,2-b]-1,2,4-triazin-7-one derivatives as dual binding site acetylcholinesterase inhibitors.
    Liu S; Shang R; Shi L; Zhou R; He J; Wan DC
    Chem Biol Drug Des; 2014 Aug; 84(2):169-74. PubMed ID: 24890706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.
    Kwon YE; Park JY; No KT; Shin JH; Lee SK; Eun JS; Yang JH; Shin TY; Kim DK; Chae BS; Leem JY; Kim KH
    Bioorg Med Chem; 2007 Oct; 15(20):6596-607. PubMed ID: 17681794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy.
    Wilkinson DG; Francis PT; Schwam E; Payne-Parrish J
    Drugs Aging; 2004; 21(7):453-78. PubMed ID: 15132713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel Pyridine-Containing Sultones: Structure-Activity Relationship and Biological Evaluation as Selective AChE Inhibitors for the Treatment of Alzheimer's disease.
    Zhang H; Wu C; Chen X; Zhang Z; Jiang X; Qin HL; Tang W
    ChemMedChem; 2021 Oct; 16(20):3189-3200. PubMed ID: 34036731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis, Molecular Modeling, and Evaluation of Novel Sulfonylhydrazones as Acetylcholinesterase Inhibitors for Alzheimer's Disease.
    Fernandes TB; Cunha MR; Sakata RP; Candido TM; Baby AR; Tavares MT; Barbosa EG; Almeida WP; Parise-Filho R
    Arch Pharm (Weinheim); 2017 Nov; 350(11):. PubMed ID: 28940630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discovery of novel dual acetylcholinesterase inhibitors with antifibrillogenic activity related to Alzheimer's disease.
    de Almeida JR; Figueiro M; Almeida WP; de Paula da Silva CHT
    Future Med Chem; 2018 May; 10(9):1037-1053. PubMed ID: 29676170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Target Enzyme in Alzheimer's Disease: Acetylcholinesterase Inhibitors.
    Saxena M; Dubey R
    Curr Top Med Chem; 2019; 19(4):264-275. PubMed ID: 30706815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Systematic Review on Donepezil-based Derivatives as Potential Cholinesterase Inhibitors for Alzheimer's Disease.
    Korabecny J; Spilovska K; Mezeiova E; Benek O; Juza R; Kaping D; Soukup O
    Curr Med Chem; 2019; 26(30):5625-5648. PubMed ID: 29768996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploration of dual fatty acid amide hydrolase and cholinesterase inhibitory potential of some 3-hydroxy-3-phenacyloxindole analogs.
    Tripathi RKP; Ayyannan SR
    Arch Pharm (Weinheim); 2020 Sep; 353(9):e2000036. PubMed ID: 32573008
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Review on Recent Development of Novel Heterocycles as Acetylcholinesterase Inhibitor for the Treatment of Alzheimer's Disease.
    Patel A; Shah D; Patel Y; Patel S; Mehta M; Bambharoliya T
    Curr Drug Targets; 2023; 24(3):225-246. PubMed ID: 36515018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel tacrine analogues for potential use against Alzheimer's disease: potent and selective acetylcholinesterase inhibitors and 5-HT uptake inhibitors.
    McKenna MT; Proctor GR; Young LC; Harvey AL
    J Med Chem; 1997 Oct; 40(22):3516-23. PubMed ID: 9357518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acetylcholinesterase Enzyme Inhibitor Molecules with Therapeutic Potential for Alzheimer's Disease.
    Sivaraman B; Raji V; Velmurugan BA; Natarajan R
    CNS Neurol Disord Drug Targets; 2022; 21(5):427-449. PubMed ID: 34602041
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.